News
Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...
Clinical Trials Arena on MSN2d
GSK and Spero halt UTI antibiotic trial early due to high efficacyGSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...
InvestorsHub on MSN3d
Spero Therapeutics Stock Skyrockets on Strong Phase 3 Trial ResultsSpero Therapeutics, Inc. (NASDAQ:SPRO) saw its stock soar by 240% after announcing highly encouraging results from its Phase ...
GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...
In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback